Date and time
Start: Wednesday 15 July 2020, 12:30 PM
End: Wednesday 15 July 2020, 01:30 PM
Wednesday 15 July
Start: Wednesday 15 July 2020, 12:30 PM
End: Wednesday 15 July 2020, 01:30 PM
Is there anything “difficult or mysterious” about identifying a principle of general application? How does it save a patent from an insufficiency attack? When may a claim incorporating such a principle cover inventive improvements without being insufficient? And, does the Supreme Court’s decision in Regeneron v Kymab answer any of these questions?
Justin Lambert has closely followed the progress of this case through the UK Courts, attended the UKSC hearing and been involved in related overseas litigation concerning the same technology. Justin will lead this webinar in which he will address the above questions and explain the significance of the terms “hybrid antibody”, “immunological sickness” and “reverse chimeric locus” that are key to understanding the Supreme Court decision.
Fellows, Students
Justin has more than 20 years’ experience specialising in intellectual property matters in England and in Australia. He worked for many years as a solicitor for a magic circle firm in London before progressing his career in senior leadership roles with two of Australia’s most respected intellectual property firms. He has a background in science, having studied chemistry and pure maths, and is recognised as a leading patent lawyer. Together with his fellow principal, John Hornby, Justin established the firm Lambert Hornby Limited in 2018.
The event has been added to your basket:
Sign in to your account to register for the event
If you are not yet registered or a member of CIPA, please register here